A method for production of artificial skin by administering matrix
metalloproteinase inhibitor or matrix metalloproteinase inhibitor and
matrix protein production promoting agent. The matrix metalloproteinase
inhibitor is
N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](3-picolyl)amino]-3-methylbuta-
namide hydrochloride.